NASDAQ:ABSI Absci Q3 2026 Earnings Date & Estimates $8.74 -0.36 (-3.96%) Closing price 10/14/2026 04:00 PM EasternExtended Trading$8.60 -0.14 (-1.54%) As of 09:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Absci is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. The conference call is scheduled for 8:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 12, 2026TimeAfter Market ClosesConference Call8:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Absci in Q3 2026Absci is expected to post earnings of -$0.1898 per share on revenue of $0.70 million. In the same quarter a year earlier Absci reported -$0.20 per share on revenue of $0.38 million. Absci last reported on August 11, 2026, posting -$0.21 per share and missing the -$0.1910 consensus estimate. Absci has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.1898Expected Revenue$0.70 millionPrior-Year EPS-$0.20Prior-Year Revenue$0.38 millionExpected Revenue Growth+84.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.21 (Missed by -$0.0190)Last Quarter Revenue$0.32 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Absci Q3 2026 Earnings FAQ When does Absci report Q3 2026 earnings? Absci (NASDAQ:ABSI) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Absci's Q3 2026 earnings call? Absci's Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Absci? Analysts expect Absci to post earnings of -$0.1898 per share for Q3 2026. How much revenue is Absci expected to report? The consensus revenue estimate for Absci is $0.70 million for Q3 2026. Absci Earnings HeadlinesAbsci (NASDAQ:ABSI) Stock Gets Price Target Increase from JPMorgan Chase & Co.October 14 at 1:18 AM | americanbankingnews.comAbsci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026October 13 at 8:00 AM | globenewswire.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.October 15 at 1:00 AM | Banyan Hill Publishing (Ad)Absci (NASDAQ:ABSI) Stock Rating Reaffirmed as "Buy" by HC WainwrightOctober 12 at 8:07 AM | americanbankingnews.comAbsci (ABSI) Stock Dropped, So What Is Behind The Latest Attention?October 7, 2026 | finance.yahoo.comAbsci Corporation (NASDAQ:ABSI) Stock Rated "Moderate Buy" by Sell-Side AnalystsOctober 4, 2026 | americanbankingnews.comSee More Absci Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Absci? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Absci and other key companies, straight to your email. Email Address About AbsciAbsci (NASDAQ:ABSI) is a biotechnology company that uses generative artificial intelligence and integrated laboratory technologies to discover and develop new medicines. The company focuses primarily on biologics, including antibody-based therapies, and aims to accelerate the process of moving from drug concept to candidate development. Absci’s platform combines artificial intelligence models with biological data generation and laboratory experimentation. Its capabilities include protein and antibody design, target and candidate evaluation, and the development of cell lines and manufacturing processes intended to support biologic drug production. The company also works with pharmaceutical and biotechnology partners on drug discovery and development programs. Founded in 2011, Absci is headquartered in Vancouver, Washington, and serves the global biopharmaceutical industry through its technology platform and collaborations. Founder Sean McClain serves as the company’s chief executive officer.View Absci ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Citi Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenUnitedHealth Beats on Earnings, But Investors Question Growth PathIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver?PBF Energy's Stunning Rally Faces a Critical TestA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Albertsons Is Betting on a Turnaround—But Will It Pay Off? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
